pyrazolanthrone has been researched along with Lymph Node Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, C; Jiang, B; Liu, H; Shi, X | 1 |
| Chou, MY; Hu, FW; Lee, SS; Tsai, CH; Wang, TH; Yang, LC; Yu, CC | 1 |
2 other study(ies) available for pyrazolanthrone and Lymph Node Metastasis
| Article | Year |
|---|---|
ZCCHC9 promotes proliferation and invasion of lung cancer through regulating the JNK pathway.
Topics: A549 Cells; Anthracenes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cytoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; MAP Kinase Signaling System; Middle Aged; Nuclear Proteins; RNA-Binding Proteins | 2019 |
Knockdown of S100A4 impairs arecoline-induced invasiveness of oral squamous cell carcinomas.
Topics: Anthracenes; Areca; Carcinoma, Squamous Cell; Chromones; Enzyme Inhibitors; Female; Humans; Lymphatic Metastasis; Male; Mastication; Morpholines; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; S100 Calcium-Binding Protein A4; S100 Proteins; Survival Rate | 2015 |